Raffaele Dubbioso Selected Research

Idiopathic dilation cardiomyopathy

4/2015

Muscle fiber type disproportion (FTD) in a family with mutations in the LMNA gene.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raffaele Dubbioso Research Topics

Disease

4	Cognitive Dysfunction 11/2019 - 04/2014
3	Multiple Sclerosis 04/2022 - 01/2015
3	Dementia (Dementias) 10/2021 - 09/2009
3	Type C Niemann-Pick Disease (Niemann Pick Disease, Type C) 11/2019 - 04/2014
2	Disease Progression 01/2021 - 11/2020
2	Hepatolenticular Degeneration (Wilson's Disease) 03/2020 - 03/2016
2	Alzheimer Disease (Alzheimer's Disease) 11/2019 - 04/2014
2	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 04/2019 - 09/2017
1	Chronic Progressive Multiple Sclerosis 09/2022
1	Myoclonic Epilepsies (Myoclonic Encephalopathy) 01/2022
1	Juvenile Myoclonic Epilepsy 01/2022
1	Amyloid Plaque 06/2021
1	Transthyretin-Related Hereditary Amyloidosis 06/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2020
1	Parkinsonian Disorders (Parkinsonism) 03/2020
1	Neurodegeneration with brain iron accumulation (NBIA) 03/2020
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2020
1	Iron Overload 03/2020
1	COVID-19 01/2020
1	Demyelinating Diseases (Demyelinating Disease) 01/2020
1	Epilepsy (Aura) 01/2020
1	Myoclonus (Nocturnal Myoclonus) 01/2020
1	Rett Syndrome (Rett's Disorder) 06/2019
1	Sialorrhea 06/2019
1	Bruxism 06/2019
1	Fatigue 04/2019
1	Neurologic Manifestations (Neurological Manifestations) 06/2018
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2018
1	Neuroacanthocytosis 07/2017
1	Pain (Aches) 01/2017
1	Inborn Genetic Diseases (Disease, Hereditary) 03/2016
1	Idiopathic dilation cardiomyopathy 04/2015
1	Type 2B1 Charcot-Marie-Tooth disease 04/2015
1	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 04/2015
1	Laminopathies 04/2015
1	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 04/2015
1	Lipodystrophy 04/2015
1	Progeria (Hutchinson Gilford Syndrome) 04/2015
1	Stroke (Strokes) 01/2015
1	Oculopharyngeal Muscular Dystrophy 05/2012
1	Hallucinations (Hallucination) 09/2009
1	Parkinson Disease (Parkinson's Disease) 09/2009

Drug/Important Bio-Agent (IBA)

3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
3	LipidsIBA 01/2022 - 06/2018
3	Cholinergic Agents (Cholinergics)IBA 01/2019 - 09/2009
2	ocrelizumabIBA 09/2022 - 04/2022
2	Amyloid (Amyloid Fibrils)IBA 06/2021 - 11/2019
2	CopperIBA 03/2020 - 03/2016
2	Pharmaceutical PreparationsIBA 01/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 09/2017 - 04/2015
1	Monoclonal AntibodiesIBA 04/2022
1	Prealbumin (Transthyretin)IBA 06/2021
1	EdaravoneIBA 11/2020
1	IronIBA 03/2020
1	Familial apoceruloplasmin deficiencyIBA 03/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2020
1	bis(tri- n- hexylsiloxy)(2,3- naphthalocyaninato)silicon (SINC)IBA 01/2020
1	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 11/2019
1	Botulinum Toxins (Botulinum Toxin)IBA 06/2019
1	miglustat (Zavesca)FDA Link 06/2018
1	atalurenIBA 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 07/2017
1	Therapeutic UsesIBA 01/2017
1	Lamin Type A (Lamin A)IBA 04/2015
1	polyalanineIBA 05/2012
1	Poly(A)-Binding Protein IIIBA 05/2012

Therapy/Procedure

5	Therapeutics 09/2022 - 06/2018
5	Transcranial Magnetic Stimulation 01/2022 - 11/2019
2	Transcranial Direct Current Stimulation 01/2017 - 01/2015
1	Autonomic Denervation 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Denervation 01/2019
1	Cognitive Training 01/2017